«Weibel-Palade Bodies

Below is an extended Weibel-Palade Bodies patents listing. Click here to return to the Weibel-Palade Bodies main in depth entry.

Patents :
US Patent No.	Title
5976540	Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
6235309	Inhibition of cell-cell binding by lipid assemblies
6277975	Fusions of P-selectin ligand protein and polynucleotides encoding same
6299897	Inhibition of selectin binding
6309639	Method for inhibiting an inflammatory response using antibodies to P-selectin glycoprotein ligand
6315995	Methods for treating an ischemic disorder and improving stroke outcome
6316403	Methods for treating an ischemic disorder and improving stroke outcome
6334872	Method for treating diseased or damaged organs
6413760	Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof
6419921	DNA-constructs of blood clotting factors and P-Selectin
6423316	Anticoagulant fusion protein anchored to cell membrane
6230713	Determining a treatment plan for patients undergoing thrombotic event by monitoring P-selectin
6228837	Endothelial monocyte activating polypeptide II: a mediator which activates host response
6210670	Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin
5985852	Inhibition of selectin binding
6008193	Methods of using human von Willebrand factor GPIb binding domain polypeptides
6033667	Method for detecting the presence of P-selectin
6066321	Method for antagonizing vascular adhesion protein-1 (VAP-1)-mediated binding of endothelial cells to lymphocytes
6111065	Peptide inhibitors of inflammation mediated by selectins
6124267	O-glycan inhibitors of selectin mediated inflammation derived from PSGL-1
6146849	Lectins and coding sequences
6159443	X-ray guided drug delivery
6191271	Synthetic divalent sLex containing polylactosamines and methods for use
6193979	Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligands
6489290	Antiplatelet agent
6500810	Method of regulating expression of adhesion molecules on circulating leukocytes
7101707	Secondary sprouting for isolation and expansion of endothelial sprout cells and endothelial precursor cells from a mixed population and for screening substances
7176023	Endothelial cells derived from primate embryonic stem cells
7247477	Methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
7252820	Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof
7304039	Glucose-based compounds with affinity to P-selectin
7354763	Generating vascular smooth muscle cells in vitro from ES cells
7358055	Diagnostic markers of acute coronary syndrome and methods of use thereof
7361473	Diagnostic markers of acute coronary syndrome and methods of use thereof
7387777	Methods of treating hemophilia or von willebrand disease with p-selectin
7399847	Nucleic acids encoding artificial P-selectin ligands
7049140	X-ray guided drug delivery
6890351	Method for treating diseased or damaged organs
6881404	Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereof
6506382	Method for inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand
6524820	Lectins and coding sequences
6528487	Peptide inhibitors of inflammation mediated by selectins
6537553	Leukosialin: Ig fusion proteins
6538028	Method for inhibiting complement activation
6663886	Inhibition of cell-cell binding by lipid assemblies
6667036	Methods of treatment using antibodies to P-selectin glycoprotein ligand
6689764	Treatment of angiogenesis dependent conditions with dextrin sulphate
6734168	Endothelial monocyte activating polypeptide II: a mediator which activates host response
6852497	Methods of identifying compounds which inhibit binding of SLIC-1 to PSGL-1
7405272	Selectin ligand interactor cytoplasmic (SLIC-1), a P-selectin glycoprotein ligand (PSGL-1) binding protein

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.